Cover Image
Market Research Report

Global Drug Discovery Outsourcing Market 2018-2022

Published by TechNavio (Infiniti Research Ltd.) Product code 607183
Published Content info 123 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Drug Discovery Outsourcing Market 2018-2022
Published: February 16, 2018 Content info: 123 Pages
Description

About Drug Discovery Outsourcing

Drug discovery outsourcing refers to the outsourcing of drug discovery processes to contract manufacturers to reduce the time taken for development of a drug or to scale-up production, enjoy premium pricing, increase market share, reduce costs, and serve the local markets.

Technavio's analysts forecast the global drug discovery outsourcing market to grow at a CAGR of 12.13% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global drug discovery outsourcing market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Drug Discovery Outsourcing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Charles River
  • Domainex
  • EVOTEC
  • GenScript
  • GVK Biosciences

Market driver

  • Prioritization of core competencies
  • For a full, detailed list, view our report

Market challenge

  • Limited manufacturing standardization
  • For a full, detailed list, view our report

Market trend

  • Increased demand for regenerative medicine
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents
Product Code: IRTNTR20430

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Small molecules- Market size and forecast 2017-2022
  • Biologics - Market size and forecast 2017-2022
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Increased demand for regenerative medicine
  • Increased number of M&A
  • Presence of value-added services

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Charles River
  • Domainex
  • EVOTEC
  • GenScript
  • GVK Biosciences
  • Laboratory Corporation of America
  • Other prominent vendors

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Related market
  • Exhibit 02: Market characteristics
  • Exhibit 03: Market segments
  • Exhibit 04: Market definition - Inclusions and exclusions checklist
  • Exhibit 05: Market size 2017
  • Exhibit 06: Validation techniques employed for market sizing 2017
  • Exhibit 07: Global drug discovery outsourcing market - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 08: Global drug discovery outsourcing market - Year over year growth 2018-2022 (%)
  • Exhibit 09: Five forces analysis 2017
  • Exhibit 10: Five forces analysis 2022
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2017-2022
  • Exhibit 17: Product - Market share 2017-2022 (%)
  • Exhibit 18: Comparison by product
  • Exhibit 19: Small molecules- Market size and forecast 2017-2022 ($ bn)
  • Exhibit 20: Characteristics of small molecules drugs compared with biologics
  • Exhibit 21: Small molecules- Year over year growth 2018-2022 (%)
  • Exhibit 22: Biologics- Market size and forecast 2017-2022 ($ bn)
  • Exhibit 23: Biologics- Year over year growth 2018-2022 (%)
  • Exhibit 24: Popular biologics
  • Exhibit 25: Market opportunity by product
  • Exhibit 26: Customer landscape
  • Exhibit 27: Global - Market share by geography 2017-2022 (%)
  • Exhibit 28: Regional comparison
  • Exhibit 29: Americas - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 30: Americas - Year over year growth 2018-2022 (%)
  • Exhibit 31: Top three countries in Americas
  • Exhibit 32: EMEA - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 33: EMEA - Year over year growth 2018-2022 (%)
  • Exhibit 34: Top three countries in EMEA
  • Exhibit 35: APAC - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 36: APAC - Year over year growth 2018-2022 (%)
  • Exhibit 37: Top three countries in APAC
  • Exhibit 38: Market opportunity
  • Exhibit 39: Competitive advantage among vendors
  • Exhibit 40: Examples of global pharmaceutical companies sourcing from contract manufacturers
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendors Covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendors
  • Exhibit 47: Vendor overview
  • Exhibit 48: Charles River - Business segments
  • Exhibit 49: Charles River - Organizational developments
  • Exhibit 50: Charles River - Geographic focus
  • Exhibit 51: Charles River - Segment focus
  • Exhibit 52: Charles River - Key offerings
  • Exhibit 53: Vendor overview
  • Exhibit 54: Domainex - Business segments
  • Exhibit 55: Domainex - Organizational developments
  • Exhibit 56: Domainex - Geographic focus
  • Exhibit 57: Domainex - Segment focus
  • Exhibit 58: Domainex - Key offerings
  • Exhibit 59: Vendor overview
  • Exhibit 60: EVOTEC- Business segments
  • Exhibit 61: EVOTEC- Organizational developments
  • Exhibit 62: EVOTEC- Geographic focus
  • Exhibit 63: EVOTEC- Segment focus
  • Exhibit 64: EVOTEC- Key offerings
  • Exhibit 65: Vendor overview
  • Exhibit 66: GenScript- Business segments
  • Exhibit 67: GenScript- Organizational developments
  • Exhibit 68: GenScript- Geographic focus
  • Exhibit 69: GenScript- Segment focus
  • Exhibit 70: GenScript- Key offerings
  • Exhibit 71: Vendor overview
  • Exhibit 72: GVK Biosciences- Business segments
  • Exhibit 73: GVK Biosciences- Organizational developments
  • Exhibit 74: GVK Biosciences- Geographic focus
  • Exhibit 75: GVK Biosciences- Segment focus
  • Exhibit 76: GVK Biosciences- Key offerings
  • Exhibit 77: Vendor overview
  • Exhibit 78: Laboratory Corporation of America- Business segments
  • Exhibit 79: Laboratory Corporation of America- Organizational developments
  • Exhibit 80: Laboratory Corporation of America- Geographic focus
  • Exhibit 81: Laboratory Corporation of America- Segment focus
  • Exhibit 82: Laboratory Corporation of America- Key offerings
Back to Top